Cleared Traditional

K874242 - JEHLE CORONARY PERFUSION CATHETERS

K874242 is an FDA 510(k) clearance for JEHLE CORONARY PERFUSION CATHETERS, manufactured by Pilling Co.. The device is a Class 2 Cardiovascular device with product code KRA cleared through the Traditional 510(k) pathway after a 52-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1987
Decision
52d
Days
Class 2
Risk

K874242 is an FDA 510(k) clearance for the JEHLE CORONARY PERFUSION CATHETERS. Classified as Catheter, Continuous Flush (product code KRA), Class II - Special Controls.

Submitted by Pilling Co. (Fort Washington, US). The FDA issued a Cleared decision on December 7, 1987 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pilling Co. devices

FDA 510(k) Submission Details - K874242

510(k) Number K874242 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 16, 1987
Decision Date December 07, 1987
Days to Decision 52 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 125d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KRA Device Classification - Class 2, Special Controls

Product Code KRA Catheter, Continuous Flush
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRA Catheter, Continuous Flush

All 136
Devices cleared under the same product code (KRA) and FDA review panel - the closest regulatory comparables to K874242.
VAMP VENOUS/ARTERIAL BLOOD MANAGEMENT PROTECTION
K896819 · Baxter Healthcare Corp · Jan 1990
VAMP VENOUS/ARTERIAL BLOOD MANAGEMENT PROTECTION
K885281 · Baxter Healthcare Corp · Mar 1989
JEHLE CORONARY PERFUSION CATHETERS
K884946 · Pilling Co. · Feb 1989
ANGIO-FLO CONTINUOUS ARTERIAL CATH FLUSH DEVICE
K860570 · Parke-Davis Co. · Mar 1986
ANGIO-FLO CONTIN-ARTERIAL FLUSH DEV.
K832058 · Parke-Davis Co. · Sep 1983
CONTINUOUS FLUSH DEVICE
K831730 · American Pharmaseal Div. Ahsc · Jul 1983